CN105935441A - Application of polypeptide in preparation of TTX-R type sodium channel tool molecule - Google Patents

Application of polypeptide in preparation of TTX-R type sodium channel tool molecule Download PDF

Info

Publication number
CN105935441A
CN105935441A CN201610234427.7A CN201610234427A CN105935441A CN 105935441 A CN105935441 A CN 105935441A CN 201610234427 A CN201610234427 A CN 201610234427A CN 105935441 A CN105935441 A CN 105935441A
Authority
CN
China
Prior art keywords
ttx
sodium channel
aranea
sodium
presses down
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610234427.7A
Other languages
Chinese (zh)
Inventor
邓梅春
罗旋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qin Cai Bio Tech Ltd Changsha
Original Assignee
Qin Cai Bio Tech Ltd Changsha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qin Cai Bio Tech Ltd Changsha filed Critical Qin Cai Bio Tech Ltd Changsha
Priority to CN201610234427.7A priority Critical patent/CN105935441A/en
Publication of CN105935441A publication Critical patent/CN105935441A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses an application of a bioactive polypeptide in preparation of a voltage-gated sodium channel tool reagent-TTX-R type sodium channel inhibitor. The bioactive polypeptide is spider sodium-inhibiting peptide-IX (SPNP-IX); tests verify that the active polypeptide has an obvious inhibitory effect on a TTX-R type voltage-gated sodium channel. In the preparation of the voltage-gated potassium channel subtype tool reagent, the extracellular dosing concentration is made to be 100 nmol/L or 500 nmol/L. The 50% effect dose IC50 of the SPNP-IX is 530 nmol/L. The inhibition of the SPNP-IX on the TTX-R type sodium channel shows time compliance, and the SPNP-IX is a good TTX-R type sodium channel tool reagent.

Description

The application in preparing TTX-R type sodium channel tool molecule of one peptide species
Technical field
The present invention relates to a kind of active polypeptide purposes in ion channel tool reagent, especially prepare with chemical method Guangxi tassel hair spider Toxic extraction thing-Aranea presses down sodium peptide-IX(and is abbreviated as SPNP-IX) preparing the examination of voltage-gated sodium channel instrument Purposes in the inhibitor of agent-TTX-R type sodium channel.
Background technology
Voltage-gated sodium channel is distributed widely in the excitabilities such as neuron, cardiac muscle, vascular smooth muscle, pancreas, skeletal muscle In tissue, be a kind of important transmembrane structure albumen, its participate in regulation secretion of neurotransmitter, vasoconstriction, pancreatic secretion and The various physiological processes such as skeletal muscle irritability, are also simultaneously one of the important targets of medicine effect.Sodium channel is at action electricity Key effect in the generation of position and communication process, voltage-gated sodium channel becomes the action target of a lot of animals and plants toxin. The structure-function relationship research of sodium-ion channel has become as international study hotspot.Voltage-gated sodium channel is likely to into Critical treatment target spot for the disease such as nerve and cardiovascular.The zootoxin of nature be a class have the highest practical value and The tool reagent of application prospect or drug targeting material, be not only venomous animal and resist the powerful mean of natural enemy, be also to be engaged in god Through biology and Physiologic Studies, the exploitation of natural original new drug and the valuable materials of protein basic research, also grind simultaneously Study carefully the uniqueness " molecular probe and decipher " of ion channel.Up to now, from many animals (as scorpion, Aranea, Serpentis and ocean are dynamic Thing etc.) venom in identified the active component of a lot of batrachotoxin.They are by the diverse location phase with sodium channel In conjunction with thus cause the dynamic characteristic of passage that corresponding change occurs, as passage de-inactivation, passage mouth, easily change activation, Inactivation delays.By illustrating the molecular mechanism of these specificity modulator batrachotoxins, except going deep in theory Speculate outside the functional activity difference between the hypotype of sodium channel and gate active mechanism, it is also possible to for they being developed into the treatment mankind The new drug of relevant disease provides sufficient theoretical basis and wide application prospect.
Summary of the invention
It is contemplated that in provide a kind of Guangxi tassel hair spider Toxic extraction thing-Aranea press down sodium peptide-IX prepare valtage-gated The application of tool reagent-TTX-R type sodium channel, sodium channel inhibitor, described Guangxi tassel hair spider Toxic extraction thing-Aranea presses down sodium Peptide-IX(is abbreviated as SPNP-IX), its aminoacid sequence is:
NH2-Glu Cys Thr Lys Leu Leu Gly Gly Cys Thr Lys Asp Ser Glu Cys Cys Pro
His Leu Gly Cys Arg Lys Lys Trp Pro Tyr His Cys Gly Trp Asp Gly Thr Phe- NH2,
It is characterized in that Guangxi tassel hair spider Toxic extraction thing-Aranea presses down sodium peptide-IX as single effective active component for preparing TTX-R type sodium channel inhibitor.
Described Aranea presses down between the 2nd cysteine of N end and the 16th cysteine of sodium peptide-IX, the 9th half, N end Between cystine and the 21st cysteine, between the 15th cysteine of N end and the 29th cysteine, form two sulfur respectively Key.
This Aranea presses down sodium peptide-IX as single effective active component for preparing TTX-R type sodium channel inhibitor, with cell The mode of external administration is prepared as TTX-R type sodium channel tool reagent.
Aranea presses down sodium peptide-IX preparing TTX-R type sodium channel tool reagent or during inhibitor, the agent that preparation extracellular is administered Amount is 100 nmol/L or 500 nmol/L.
Aranea presses down the half useful effect dosage IC of sodium peptide-IX suppression TTX-R type sodium channel50It is 530 nmol/L.
Aranea presses down the sodium peptide-IX suppression presentative time compliance to TTX-R type sodium channel, is a kind of preferably TTX-R type Sodium channel tool reagent.
Accompanying drawing explanation
Fig. 1 is that 100 nmol/L SPNP-IX are on the impact of TTX-R type sodium channel on rat drg neuron.
Fig. 2 is that 500 nmol/L SPNP-IX are on the impact of TTX-R type sodium channel on rat drg neuron.
Fig. 3 is SPNP-IX m-effect relation curve when acting on rat DRG cell TTX-R sodium channel.
Fig. 4 is concentration-effect relation curve that SPNP-IX acts on rat DRG cell TTX-R sodium channel.
Fig. 5 is the SPNP-IX impact on rat DRG cell TTX-R sodium channel current-voltage relationship.
Fig. 6 is the SPNP-IX impact on rat DRG cell TTX-R sodium channel Conductance-Voltage relation.
Fig. 7 is the SPNP-IX dynamic (dynamical) impact of Steady-state inactivation on rat DRG cell TTX-R sodium channel.
Detailed description of the invention
In order to be better understood from and more fully disclose the present invention, the rat back of the body will be used by extracellular route of administration below Root neural section cell model illustrates that Aranea presses down the TTX-R type sodium channel inhibitory action of sodium peptide-IX.
1, experiment material and method
The acute isolation of 1.1 dorsal root ganglion neurons (DRG cell) is cultivated
Select birth about 4 weeks, the SD rat of body weight 140~200 g, take out rapidly vertebra also with scissors at disconnected neck after death It is cut into 2~3 sections, then along the direction vertical with rib plane, canalis spinalis is cut off, and be immersed in the beaker filling a small amount of culture fluid; Tear the one layer of mucosa being attached on canalis spinalis inwall with tweezers, expose the Dorsal ganglion fiber of the intersection being positioned at canalis spinalis and rib. In Thoracolumbar disk section, can select in about 18 culture dishs being placed into filling 2 mL culture fluid;Under anatomic microscope, use tip Tweezers and Wei Nasi cut and isolate neuroganglion.Peel off after wrapping in the floccule outside joint and axon, put into and fill about 0.5 mL cultivation In the culture dish of liquid.Suck liquid with suction pipe, all neuroganglions of separator well are shredded, the most broken more good.After shredding, proceed to disappear Change liquid, 34 DEG C, the environment of concussion frequency 110 rpm carries out enzymolysis, digestion and reacts 20 min.Period takes out every 10 min Inhale with liquid-transfering gun and beat for several times;In Digestive system, add pancreatin inhibitor, terminate enzymolysis.The Cell sap that digestion is obtained by sterile working Proceed to centrifuge tube is centrifuged (800 rpm, 5 min), remove supernatant, add 8 mL long-term cultivation liquid containing 10% calf serum. It is divided into 3~4 wares after re-suspended cell, puts into incubator (5%CO2, 95% air) in, 37 DEG C cultivate 3~4 h adherent.
1.2 patch-clamp electrophysiologic activity experiments
Patch clamp experiments is all carried out in room temperature (25 ± 1 DEG C), uses whole-cell patch-clamp recording technique.Select smooth visible, the born of the same parents of plasma membrane Matter uniform DRG cell or have the HEK293T cell of green fluorescence as experimental cell.Electric current record passes through full cell patch Tongs technology utilizes EPC9 amplifier (HEKA company, German) to carry out on computers.Computer recording and the system of analysis use Pulse+Pulsefit 8.0 software.Glass electrode pipe is borosilicate glass capillary tube (Nanjing spring water education experiment equipment Factory).Glass electrode two step draws and forms, and polished instrument (Narishige, Japan) polishing rear electrode tip diameter is about 3 m, Charging electrode solution rear electrode resistance is 1-3M Ω.Patch clamp experiments to be carried out at ambient temperature, temperature in whole experimentation Variation the most up and down less than 2 DEG C.Use SigmaPlot 9.0 software analysis experimental result.
2, experimental result and analysis
2.1 SPNP-IX impact on TTX-R type voltage-gated sodium channel
We have detected the SPNP-IX impact on DRG cell TTX-R type voltage-gated sodium channel.Result as shown in Figure 1, 2, The SPNP-IX of 100nM and 500 nM has obvious inhibitory action to TTX-R sodium channel, and maximal percentage inhibition is respectively 21 ± 2% (n=5) and 54 ± 4% (n=4).And, it is different from other spider venom (such as JZTX-I), when SPNP-IX part suppression After sodium current, the shape of electric current is consistent with comparison current shape, illustrates that they the most substantially change the activation of sodium current and inactivation Dynamic characteristic, thus it is presumed that toxin binding site on sodium channel is not likely to be site 3.SPNP-IX suppresses TTX-R Type sodium current speed is the most very fast, has time dependent.When concentration is 10 μMs, can reach within the time of about 2 min To the suppression degree (Fig. 4) of 100%.The time constant of the SPNP-IX suppression DRG cell TTX-R sodium current of 10 μMs is 21.2 ± 1.7 s (n = 5).And the SPNP-IX of 10 μMs is about 97% to the suppression ratio of the TTX-R sodium channel of tranquillization closed mode, Show that SPNP-IX all has similar affinity to being in tranquillization closedown with the sodium channel of state of activation.SPNP-IX is to rat DRG The suppression of cell TTX-R sodium channel current has concentration compliance, their half effective inhibition concentration (IC50) it is 530 Nmol/L (Fig. 4).When dose curve is with Hill formula fitting, can draw the Hill coefficient of concentration-response curve, size is 0.95。
2.2 SPNP-IX impact on TTX-R type voltage-gated sodium channel state of activation
Under whole cell voltage clamp recording pattern, cell is clamped down on when-80 mV, give a series of test voltage respectively, its Excursion is-80~+60 mV, and stride is+10 mV, and the persistent period is 50 ms, can obtain TTX-R on rat DRG cell Current-voltage (I-V) graph of relation of sodium channel, and the activation threshold of passage, peak inrush current activation electricity can be disclosed Pressure and reversal potential size.Under the conditions of blank, when cell membrane potential is clamped down at-80 mV, initiateing of TTX-R sodium channel Activating voltage and be about-40 mV, maximum current peak activates voltage and is about-10 mV, and reversal potential is about+25 mV.At cell Around add the SPNP-IX of 500 nM, allow after toxin and cytosis 3 min, then stimulate induction I-V with identical depolarization Curve, result such as Fig. 5.SPNP-IX can make the initial activation potential of TTX-R and TTX-R sodium channel and peak point current activate voltage To direction of depolarization drift about+10 mV, but reversal potential change is inconspicuous, illustrates that toxin does not change with the interaction of passage The selectivity that variable conduit is penetrating to ion.SPNP-IX also has similar impact, energy to the Conductance-Voltage curve of TTX-R sodium channel Conductance-Voltage (G-S) relation curve of TTX-R sodium channel is caused to drift about about+10 mV(Fig. 6 toward direction of depolarization).
2.3 SPNP-IX impact on TTX-R type voltage-gated sodium channel Steady-state inactivation
We use the dipulse stimulation mode of a standard, have further looked at SPNP-IX and have led to rat DRG cell TTX-R sodium The dynamic (dynamical) impact of Steady-state inactivation in road.Dipulse stimulus parameter is: first clamped down in advance by cell membrane potential at-120 mV, continues Time is 1 s, and then transmembrane potential is changed into-80 mV, and the time is 0.5 ms, it is therefore an objective to eliminate the charging shape of cell membrane capacitance State, then depolarization current potential is transitted to-10 mV, the persistent period is 50 ms, and afterwards, transmembrane potential is returned to-80 mV.Under carrying out When once stimulating, only need to change pre-Clamping voltages (-120 mV-0 mV, stride is+10 mV), and test voltage level is same On.What Fig. 7 represented is under different pre-Clamping voltages, institute's induced current and the ratio size of maximum current (i.e.-120 mV).Will In figure, all groupings of data points Boltzmann equations are fitted, and can draw the half Steady-state inactivation voltage (V of passage1/2) value. Such as Fig. 7, for TTX-R sodium channel, under collating condition, V1/2For-38.9 ± 1.1 mV(n=7), after adding JZTX-IX, V1/2Become Become-41.9 ± 1.0 mV(n=6).Result shows that the Steady-state inactivation feature of TTX-R sodium channel is had not significant impact by SPNP-IX, And the most substantially change the slope of control curve.
SEQUENCE LISTING
<110>Changsha Qin Cai bio tech ltd
<120>Aranea presses down sodium peptide-IX
<160> 1
<170> PatentIn version 3.3
<210> 1
<211> 35
<212> PRT
<213> SPNP-IX
<400> 1
Glu Cys Thr Lys Leu Leu Gly Gly Cys Thr Lys Asp Ser Glu Cys
1 5 10 15
Cys Pro His Leu Gly Cys Arg Lys Lys Trp Pro Tyr His Cys Gly
16 20 25 30
Trp Asp Gly Thr Phe
31 35

Claims (7)

1. Guangxi tassel hair spider Toxic extraction thing-Aranea presses down sodium peptide-IX and is preparing voltage-gated sodium channel tool reagent-TTX- Application in the inhibitor of R type sodium channel, described Guangxi tassel hair spider Toxic extraction thing-Aranea presses down sodium peptide-IX(and is abbreviated as SPNP- IX), its aminoacid sequence is:
NH2-Glu Cys Thr Lys Leu Leu Gly Gly Cys Thr Lys Asp Ser Glu Cys Cys Pro
His Leu Gly Cys Arg Lys Lys Trp Pro Tyr His Cys Gly Trp Asp Gly Thr Phe- NH2,
It is characterized in that Guangxi tassel hair spider Toxic extraction thing-Aranea presses down sodium peptide-IX as single effective active component for preparing TTX-R type sodium channel inhibitor.
A kind of Guangxi the most according to claim 1 tassel hair spider Toxic extraction thing-Aranea press down sodium peptide-IX prepare valtage-gated Application in the inhibitor of tool reagent-TTX-R type sodium channel, sodium channel, it is characterised in that described Aranea presses down the N of sodium peptide-IX Hold between the 2nd cysteine and the 16th cysteine, between the 9th cysteine of N end and the 21st cysteine, N end Disulfide bond is formed respectively between 15th cysteine and the 29th cysteine.
Application process the most according to claim 1 and 2, it is characterised in that Aranea presses down sodium peptide-IX as single effective active Component is used for preparing TTX-R type sodium channel inhibitor.
Application process the most according to claim 1 and 2, it is characterised in that Aranea presses down sodium peptide-IX and is prepared as extracellular administration TTX-R type sodium channel tool reagent.
Application process the most according to claim 1 and 2, it is characterised in that Aranea presses down sodium peptide-IX at preparation TTX-R type sodium When passage tool reagent or inhibitor, the dosage that preparation extracellular is administered is 100 nmol/L or 500 nmol/L.
Application process the most according to claim 1 and 2, it is characterised in that Aranea presses down the half useful effect agent of sodium peptide-IX Amount IC50It is 530 nmol/L.
Application process the most according to claim 1 and 2, it is characterised in that it is temporal dependence that Aranea presses down the effect of sodium peptide-IX 's.
CN201610234427.7A 2016-04-17 2016-04-17 Application of polypeptide in preparation of TTX-R type sodium channel tool molecule Pending CN105935441A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610234427.7A CN105935441A (en) 2016-04-17 2016-04-17 Application of polypeptide in preparation of TTX-R type sodium channel tool molecule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610234427.7A CN105935441A (en) 2016-04-17 2016-04-17 Application of polypeptide in preparation of TTX-R type sodium channel tool molecule

Publications (1)

Publication Number Publication Date
CN105935441A true CN105935441A (en) 2016-09-14

Family

ID=57151332

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610234427.7A Pending CN105935441A (en) 2016-04-17 2016-04-17 Application of polypeptide in preparation of TTX-R type sodium channel tool molecule

Country Status (1)

Country Link
CN (1) CN105935441A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107261117A (en) * 2017-06-20 2017-10-20 长沙沁才生物科技有限公司 Applications of the SPNP 27 in Kv4.3 potassium channel inhibitors are prepared

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1872878A (en) * 2006-06-22 2006-12-06 湖南师范大学 Jingzhao toxin V
CN105154515A (en) * 2015-07-08 2015-12-16 长沙沁才生物科技有限公司 Application of bioactive peptide in preparation of potassium channel subtype tool reagents
CN105148255A (en) * 2015-07-08 2015-12-16 长沙沁才生物科技有限公司 Application of natural peptide in preparation of Kv4.2 potassium channel tool reagents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1872878A (en) * 2006-06-22 2006-12-06 湖南师范大学 Jingzhao toxin V
CN105154515A (en) * 2015-07-08 2015-12-16 长沙沁才生物科技有限公司 Application of bioactive peptide in preparation of potassium channel subtype tool reagents
CN105148255A (en) * 2015-07-08 2015-12-16 长沙沁才生物科技有限公司 Application of natural peptide in preparation of Kv4.2 potassium channel tool reagents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MEICHUN DENG等: ""Jingzhaotoxin-IX, a novel gating modifier of both sodium and potassium channels from Chinese tarantula Chilobrachys jingzhao"", 《NEUROPHARMACOLOGY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107261117A (en) * 2017-06-20 2017-10-20 长沙沁才生物科技有限公司 Applications of the SPNP 27 in Kv4.3 potassium channel inhibitors are prepared

Similar Documents

Publication Publication Date Title
Pawlak et al. Irditoxin, a novel covalently linked heterodimeric three‐finger toxin with high taxon‐specific neurotoxicity
CN102247603B (en) Infusion protein with transdermal drug delivery property
CN105935441A (en) Application of polypeptide in preparation of TTX-R type sodium channel tool molecule
CN102050874B (en) Preparation method of Huwentoxin-XVI
CN109320591A (en) A kind of polypeptide OA-GL12 and its application
CN105833247A (en) Application of polypeptide to prepare KV2.1-type potassium channel tool reagent
CN105903000A (en) Application of polypeptide in preparation of TTX-S type sodium channel tool reagent
CN104062433A (en) Identification method for animal active peptide having calcium channel inhibition function
CN103145833A (en) Urechis unicinctus hemoglobin, isolation and purification thereof and application
CN105148255A (en) Application of natural peptide in preparation of Kv4.2 potassium channel tool reagents
CN107056919A (en) Applications of the SPNP 27 in TTX S sodium channels inhibitor is prepared
CN105753957A (en) Application of polypeptide in preparation of Nav1.4 sodium channel inhibitors
CN105154515A (en) Application of bioactive peptide in preparation of potassium channel subtype tool reagents
CN103788192B (en) Bufo gargarizans Cantor cecropin B gene G-CATH6 (29) and encoding gene thereof and application
CN107281466A (en) A kind of applications of polypeptide SPGP V in insect calcium channel inhibitor is prepared
CN105884877A (en) Application of polypeptide to preparation of Nav1.5 sodium channel tool reagent
CN107226853A (en) Applications of the SPNP III in Kv2.1 channel inhibitors are prepared
CN105879011A (en) Application of polypeptide to preparation of Nav1.7 sodium channel modulation preparation
CN107106643A (en) Ring-type acetylcholinesterase C-terminal peptide in the treatment or prevention of cancer or metastasis of cancer
CN102234316A (en) Polypeptides capable of enhancement of acid sensing ion channels 1a current, and use thereof
CN107236029A (en) Applications of the SPNP I in Kv2.1 potassium channel tool reagents are prepared
CN107056917A (en) A kind of application of polypeptide in Nav1.5 passage tool reagents are prepared
CN109223801A (en) A kind of new the killing agent of gastric cancer tumor stem cell and its application
Balezina et al. Study of neurotrophic activity of thrombin on the model of regenerating mouse nerve
CN107261117A (en) Applications of the SPNP 27 in Kv4.3 potassium channel inhibitors are prepared

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160914